Press Releases and Blog
Blog
Experts Underscore the Root Cause of High Prescription Drug Prices – Big Pharma’s Anti-Competitive Tactics
With so many important issues being debated today, there are few topics that health care, legal, and economic experts agree on. But the fact that
ICYMI: Pharmacy Benefit Companies Support all Members of the Supply Chain
In case you missed it, Johnny Garcia, PharmD, Senior Director, Policy at the Pharmaceutical Care Management Association (PCMA), explains the critical role pharmacy benefit companies
Experts Weigh In on the Critical Cost Saving Role of Pharmacy Benefit Companies
Health care, business, political, and economic experts all agree pharmacy benefit companies deliver significant savings and play a critical role mitigating costs and supporting access
ICYMI: Economic Experts Sound Alarm On Misguided Legislation Targeting Pharmacy Benefit Companies
Economists Explain Policies Restricting Pharmacy Benefits Will Lead To Higher Costs, Less Competition, And Fewer Choices For Employers In case you missed it, Joe Grogan,
Don’t Be Fooled: Big Pharma Keeps the Vast Majority of the Rx Dollar
A simple fact is often lost in the din of the current drug pricing debate going on in Washington D.C. and around the country: Drug
Disclosure Requirements Could Impact Manufacturer Rebates
New report finds a potential result of disclosure requirements could increase federal government costs by $134 billion over 10 years Congress continues to consider proposals
Press Releases
PCMA Statement on the Senate Finance Committee Hearing on Prescription Drug Prices in Medicare
(Washington D.C.) – Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s Senate Finance Committee hearing, “Prescription Drug Price Inflation:
PCMA Statement on the Pre-Approval Information Exchange Act
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott today issued the following statement on H.R. 7008, the Pre-approval Information Exchange (PIE) Act:
PCMA Applauds Passage of Postal Service Reform Act
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the passage of the Postal Service Reform
Medicare Part D 2023 Proposed Rule Could Increase Costs
New Milliman Analysis Shows Medicare Part D Proposed Rule Could Increase Premiums More than It Saves in Cost Sharing for Majority of Beneficiaries (Washington, D.C.) —
Rite Aid’s PBM Elixir Joins the Pharmaceutical Care Management Association
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today announced that Elixir, Rite Aid’s pharmacy benefit manager (PBM) business, is joining the trade association.
PBMs Committed to Building a More Equitable Health Care System
(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on a new report by the U.S. Health and Human
New PCMA Rx Research Corner Blog: The PBM Marketplace is More Competitive, Not Less
This week, the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee considers legislation that would lower choice in the market by creating a one-size-fits
Health Care Investors Oppose Big Drug Companies’ Patent Abuse
In case you missed it, a new article in Inside Health Policy reported that “Investors for eight major drug companies will vote throughout the spring on 11
Leading Employer Voice and Taxpayer Watchdog Raise Concerns Over S. 1339
Legislation Would Limit Options for Employers to Provide Quality Prescription Drug Coverage for Employees The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee is
PCMA’s Kristin Bass Testifies on the Value Pharmacy Benefit Companies
Bass Explains Opposition to Legislation, Risk of Drug Companies Lowering Rx Discounts On Wednesday, expert witnesses testifying before the U.S. House Committee on Energy & Commerce
PCMA Policy Forum Highlights Indispensable Value of Savings Secured by Pharmacy Benefit Companies
Speakers Discuss Pharmacy Benefit Company Innovations, Importance of Protecting Cost Saving Role, and Solutions to Improve Affordability
Recognizing the Private Market’s Ability to Meet Evolving Demand
Pharmacy Benefit Companies Innovate to Provide Choice for Clients, Lower Costs for Patients Even as Congress considers more government intervention and “drug pricing” legislation that
ICYMI: Professor Of Health Care Management Explains Critical Role of Pharmacy Benefit Companies
Dr. Lawton Burns Says PBMs are Unfairly Blamed for High Drug Prices, Should Look At Big Drug Companies In case you missed it, Lawton R.
ICYMI: Achieving An Affordable Health Care Future For Patients
In case you missed it, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), discusses the root cause of high drug prices
America’s Pharmacy Benefit Companies Secure Billions of Dollars in Savings for Taxpayers
Misguided Policies Undermining Pharmacy Benefits Would Dramatically Increase Federal Spending Pharmacy benefit companies are working every day to secure savings for patients, families, and taxpayers.
Wide Array of Community Leader Voices Oppose Legislation, S. 127, Expanding FTC Power to Pick Winners and Losers
A wide array of voices from across the country are calling on lawmakers to oppose recently reintroduced legislation, the Pharmacy Benefit Manager Transparency Act (S.127),